AIDS Therapies (Clinical Trials)

Forum Will Discuss Use of Plasma RNA in Clinical Trials

Published in AIDS Weekly, May 26th, 1997

The U.S. Food and Drug Administration will hold a meeting to promote informal discussion between the agency and the concerned community regarding issues related to an upcoming public discussion with the Antiviral Drug Product Advisory Committee on the use of plasma HIV-RNA in clinical trials.

The advisory committee meeting tentatively is scheduled for July, 1997. A meeting was held May 16 to ensure that the community perspective will be effectively represented at the upcoming advisory committee meeting.

Topics for discussion at the advisory committee meeting include: 1) The use of HIV-RNA as a clinical study endpoint in drug efficacy trials; 2)...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1997-05-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry